Subclinical Persistent Inflammation as Risk Factor for Crohn's Disease Progression: Findings From a Prospective Real-World Study of 2 Years

Clinical Gastroenterology and Hepatology（2022）

引用 3|浏览14

暂无评分

摘要

Persistent inflammation, defined simply and readily by FC >250 μg/g over 2 consecutive visits, was associated with a significantly higher risk and shorter time to occurrence of a composite outcome reflecting disease progression in asymptomatic infliximab-treated CD patients.

查看译文

关键词

Inflammatory Bowel Disease,Anti-TNF-α,C-Reactive Protein,Fecal Calprotectin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要